Skip to content
Recall Observatory FDA recall evidence

Drug product

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

D-0149-2024

November 20, 2023

Class III

Product summary

Firm
Siegfried Barbera, SL
Event
Event 93429
Status
Completed
Classification
Class III
Quantity
2016
Official record key
drug-enforcement:D-0149-2024

Official wording

Reason: Failed Dissolution Specifications

Code information: Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications